MSB 1.40% $1.09 mesoblast limited

Choice selection of SIs words!The FDA whether out of paranoia,...

  1. 30,155 Posts.
    lightbulb Created with Sketch. 1783
    Choice selection of SIs words!

    The FDA whether out of paranoia, incompetence or vested interests or various combinations thereof, has repeatedly stalled peceiving an opening of floodgates. The series of decisions have been potentially company-destroying. Props to MSB the entire team and partners who pivoted to not allow that to happen.

    Those leadership changes at the FDA are long overdue.

    The FDA instituted its Accelerated Approval Program to allow for earlier approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint.

    A surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign or other measure that is thought to predict clinical benefit but is not itself a measure of clinical benefit.

    The use of a surrogate endpoint can considerably shorten the time required prior to receiving FDA approval.
    Drug companies are still required to conduct studies to confirm the anticipated clinical benefit.

    It would be fair to receive AA for aGVHD for paediatric, but fairness hasn't been the FDA's strong suit so far.
    It's more than time for a change.






 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
0.015(1.40%)
Mkt cap ! $1.238B
Open High Low Value Volume
$1.11 $1.12 $1.08 $11.51M 10.52M

Buyers (Bids)

No. Vol. Price($)
2 17804 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.09 230637 5
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
$1.09
  Change
0.015 ( 1.85 %)
Open High Low Volume
$1.10 $1.12 $1.08 1937390
Last updated 15.59pm 03/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.